Alzheimer’s Research & Therapy, a new BioMed Central journal edited by Douglas Galasko, Todd Golde and Gordon Wilcock has just published its first articles online.

The Editors-in-Chief introduce the journal in their editorial and to celebrate its launch, we will be distributing a special print preview issue at the Alzheimer’s Association 2009 International Conference on Alzheimer’s Disease (ICAD, booth 119; Vienna, 12th – 15th July). Please come along and pick up a free copy if you are attending this meeting.

The journal aims to be the major forum for translational research into Alzheimer’s disease (AD) and will publish open access research articles of exceptional interest. Review articles and expert commentary will accompany key papers.

Our first articles include a commentary from Paul Aisen discussing how to move forwards after recent disappointing negative trial results in Alzheimer’s drug development. Patrick Kehoe proposes angiotensins and associated enzymatic pathways as important mediators of recognised but undefined links between blood pressure and AD in a review article. And Blossom Stephan et al. review the concept of ‘vascular cognitive impairment, no dementia’ (VCIND) and its application for screening individuals at increased risk of dementia secondary to vascular disease and its risk factors.

Visit the journal website to read the first articles published and to submit your next piece of research. More content will be published in the first issue of the journal in the coming weeks. All articles are currently free to access.

For more details about the journal, please visit the journal information page or contact the editorial office. To keep up to date with the latest developments, news and articles being published in this exciting new journal, please register to receive regular alerts.

Frances Mulvany
In-house Editor – Alzheimer’s Research & Therapy